1. Home
  2. TIL vs ZVIA Comparison

TIL vs ZVIA Comparison

Compare TIL & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • ZVIA
  • Stock Information
  • Founded
  • TIL 2018
  • ZVIA 2007
  • Country
  • TIL United States
  • ZVIA United States
  • Employees
  • TIL N/A
  • ZVIA N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • ZVIA Beverages (Production/Distribution)
  • Sector
  • TIL Health Care
  • ZVIA Consumer Staples
  • Exchange
  • TIL Nasdaq
  • ZVIA Nasdaq
  • Market Cap
  • TIL 171.7M
  • ZVIA 142.5M
  • IPO Year
  • TIL 2021
  • ZVIA 2021
  • Fundamental
  • Price
  • TIL $26.95
  • ZVIA $2.72
  • Analyst Decision
  • TIL Buy
  • ZVIA Hold
  • Analyst Count
  • TIL 5
  • ZVIA 2
  • Target Price
  • TIL $119.00
  • ZVIA $3.38
  • AVG Volume (30 Days)
  • TIL 316.4K
  • ZVIA 797.4K
  • Earning Date
  • TIL 05-13-2025
  • ZVIA 05-07-2025
  • Dividend Yield
  • TIL N/A
  • ZVIA N/A
  • EPS Growth
  • TIL N/A
  • ZVIA N/A
  • EPS
  • TIL N/A
  • ZVIA N/A
  • Revenue
  • TIL N/A
  • ZVIA $154,273,000.00
  • Revenue This Year
  • TIL N/A
  • ZVIA $5.66
  • Revenue Next Year
  • TIL N/A
  • ZVIA $6.76
  • P/E Ratio
  • TIL N/A
  • ZVIA N/A
  • Revenue Growth
  • TIL N/A
  • ZVIA N/A
  • 52 Week Low
  • TIL $9.62
  • ZVIA $0.62
  • 52 Week High
  • TIL $92.00
  • ZVIA $4.99
  • Technical
  • Relative Strength Index (RSI)
  • TIL 65.08
  • ZVIA 52.78
  • Support Level
  • TIL $12.60
  • ZVIA $2.73
  • Resistance Level
  • TIL $35.28
  • ZVIA $2.86
  • Average True Range (ATR)
  • TIL 3.84
  • ZVIA 0.16
  • MACD
  • TIL 1.60
  • ZVIA -0.02
  • Stochastic Oscillator
  • TIL 63.27
  • ZVIA 21.82

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

Share on Social Networks: